@treefrogtx

TreeFrog Therapeutics is a French-based biotech aiming to unlock access to #iPS #StemCell derived #CellTherapies for millions of patients. #CellTherapyForAll

 Pessac, France
treefrog.fr
Joined March 2018
  • Tweets587
  • Following587
  • Followers864
223Media
CP: #ThérapiesCellulaires: @treefrogtx passe à la fabrication industrielle grâce à une nouvelle machine aux normes BPF! Next : Transfert #CDMO en 2023. Essai clinique #Parkinson en 2024. Et 3 nouveaux encapsulateurs livrés en 2023 pour accélérer! #FT120 treefrog.fr/fr/therapies-cel…
“En octobre 2020, nous avions annoncé que nous disposerions d’un encapsulateur BPF avant la fin 2022. Exactement deux ans plus tard, la machine est livrée. Je pense que cette machine témoigne de la remarquable capacité d’exécution de TreeFrog et Invetech. Mais plus important encore, elle constitue une échéance clé. Notre encapsulateur peut désormais être utilisé pour fabriquer des produits de thérapie cellulaire utilisables en clinique. Avec 3 autres machines BPF livrées en 2023, nous allons pouvoir accélérer nos programmes internes et ceux en partenariat en immuno-oncologie et médecine régénérative.” Dr Frédéric Desdouits, Président, TreeFrog Therapeutics.

ALT “En octobre 2020, nous avions annoncé que nous disposerions d’un encapsulateur BPF avant la fin 2022. Exactement deux ans plus tard, la machine est livrée. Je pense que cette machine témoigne de la remarquable capacité d’exécution de TreeFrog et Invetech. Mais plus important encore, elle constitue une échéance clé. Notre encapsulateur peut désormais être utilisé pour fabriquer des produits de thérapie cellulaire utilisables en clinique. Avec 3 autres machines BPF livrées en 2023, nous allons pouvoir accélérer nos programmes internes et ceux en partenariat en immuno-oncologie et médecine régénérative.” Dr Frédéric Desdouits, Président, TreeFrog Therapeutics.

2
1
8
"Scaling-up iPSC-based cell therapies: towards clinical grade processes with biomimetic C-Stem technology" Next Wednesday, don't miss Senior Application Scientist Odette Becheau oral presentation at the BELSACT Scientific Meeting in #Leuven. Do not hesitate to connect with her!
1
3
596
Our #CSO Maxime Feyeux gives a snapshot of #pluripotent #stemcell #differentiation with the C-Stem™ platform. You can check the other videos answering frequently asked questions about C-Stem™ for #iPS #expansion & #differentiation here: treefrog.fr/stemcelljungle/i…
Maxime Feyeux@FeyeuxMaxime
29 Mar 2023
We get this question a lot: Can you #differentiate #pluripotent #stemcells into any cell type in C-Stem™-generated alginate capsules? Here a quick answer. Link to our latest paper on #iPSC expansion, with some trilineage data (Fig. 3): sciencedirect.com/science/ar…
1
6
716
TreeFrog Therapeutics retweeted
Lee Buckler
@celltherapy
28 Mar 2023
After the largest, longest ph 3 of any CAR-T #celltherapy, @KitePharma's Yescarta is the 1st treatment in nearly 30 yrs to show stat significant improvement in OS for initial treatment of relapsed/refractory large B-cell lymphoma versus historical SOC. europeanpharmaceuticalreview…

Kite releases pivotal CAR T therapy Phase III study results

Yescarta® is the first treatment in over 30 years to show statistically significant improvement in overall survival in R/R large B-cell lymphoma versus historical SOC.

europeanpharmaceuticalreview.com
5
10
1,268
@treefrogtx will be in #California next week ! Immuno-oncology Scientist Hélène CABANAS will attend the #InnateKillerSummit 2023, from March 28th to 30th. Do not hesitate to connect with her! #celltherapyforall
1
365
@treefrogtx' co-founder and CSO Maxime Feyeux will give a talk on scale-up at @JSRM_Official meeting (March 24). Do not hesitate to connect with him on-site or during his 2-week trip through Tokyo, Kyoto, Kobe, Osaka and Fukuoka, from March 20th to April 1st. #celltherapyforall
324
TreeFrog Therapeutics retweeted
John De Vos@_jdevos_
11 Mar 2023
The @treefrogtx alginate encapsulation system efficiency could be due to its ability to recapitulate in capsulo a 3D lumenized colony that morphologically resembles an epiblast rosette, and which has higher cell viability than 2D colonies. sciencedirect.com/science/ar…
3
6
1,144
Following our recent paper describing #hiPSC #ScaleUp in #10L #bioreactors, our CSO highlights how the C-Stem™ platform can impact the manufacturing of stem cell-derived therapies. More videos answering frequently asked questions about C-Stem™ : treefrog.fr/stemcelljungle/
Maxime Feyeux@FeyeuxMaxime
10 Mar 2023
What does the C-Stem™ platform bring to the #CellTherapy field? For once I am the one answering questions in this short video about our latest paper in #Biomaterials. 5 other videos addressing FAQS about C-Stem are online: treefrog.fr/stemcelljungle/
3
1
2
1,259
New publication demonstrating almost 300-fold #hiPSC expansion in 10L #bioreactors within 1 week with #CStem biomimetic platform with high reproducibility & preservation of cell quality. treefrog.fr/exponential-hips… @ISSCR @ISCTglobal @FSSCR_officiel @JSRM_Official @ESGCT @alliancerm
Engineering 3D micro-compartments for highly efficient and scale-independent expansion of human pluripotent stem cells in bioreactors

ALT Engineering 3D micro-compartments for highly efficient and scale-independent expansion of human pluripotent stem cells in bioreactors

1
8
1
15
2,093
TreeFrog Therapeutics retweeted
STEMCELL Technologies
@STEMCELLTech
6 Mar 2023
Happening live TOMORROW! ⚠️ This is your last chance to sign for this webinar on #pluripotent stem cells with Dr. Maxime Feyeux (@FeyeuxMaxime): bit.ly/3YVjMiw
STEMCELL Technologies
@STEMCELLTech
24 Feb 2023
What can the human body 🧍 teach us about how to scale up high-quality #pluripotent stem cells (PSCs)? Join us for a live webinar on March 7, with Dr. Maxime Feyeux (@FeyeuxMaxime), co-founder of TreeFrog Therapeutics (@treefrogtx), to find out. bit.ly/3YVjMiw
3
3
995
Releasing a pretty exhaustive list of cell therapy trials based on iPS & ES cells! Access for free and share! treefrog.fr/stemcelljungle/l… @pknoepfler @alliancerm @ISSCR @ISCTglobal @STEMCELLTech @nyscf @JSRM_Official @LINKJ20160324 @IPSCtherapies @ESC_iPSC_News
1
1
8
586
TreeFrog Therapeutics retweeted
STEMCELL Technologies
@STEMCELLTech
24 Feb 2023
What can the human body 🧍 teach us about how to scale up high-quality #pluripotent stem cells (PSCs)? Join us for a live webinar on March 7, with Dr. Maxime Feyeux (@FeyeuxMaxime), co-founder of TreeFrog Therapeutics (@treefrogtx), to find out. bit.ly/3YVjMiw
3
1
5
2,078
3/6 Gaia Biomedicine & @treefrogtx announce collaboration for the expansion of allogeneic NK-like cells against solid tumors. treefrog.fr/gaia-biomedicine…
1
2
5
323
Releasing a #whitepaper on the lumenized rosette - the 3D conformation adopted by human #PluripotentStemCells in vivo ! Properties / PSC growth & quality / comparison with 2D/aggregates / Biomimetic PSC culture in large-scale bioreactors Download : treefrog.fr/stemcelljungle/r…
2
7
985
TreeFrog Therapeutics retweeted
XAnge@XAngeVC
20 Feb 2023
It's great to see some of our #startups in the new #FT120 & #Next40 rankings! Kudos to @LeCollectionist @treefrogtx @Skelloapp @Ledger @applydia @360Learning 🤩👏
3
16
1,195
TreeFrog dans le #FT120 ! Quelle trajectoire ? Quels jalons à venir ? Quel impact en France ? 2 min avec Jean-Luc TREILLOU, co-fondateur de @treefrogtx. Bienvenue aux nouveaux entrants dans le FrenchTech120, et un grand merci à @LaFrenchTech !
4
1
10
1,860
What to find on our new scientific blog ? #1 Exclusive & free resources: a list of #CellTherapy #trials based on #Pluripotent #StemCells, a white paper on the lumenized rosette – the specific 3D conformation adopted by hPSCs in vivo, interviews... treefrog.fr/stemcelljungle/
259
Press Release : Clinical-stage Japanese biotech Gaia Biomedicine & TreeFrog Therapeutics announce collaboration for the expansion of allogeneic NK-like cells against solid tumors. Full press release: treefrog.fr/gaia-biomedicine…
1
1
4
552
@alliancerm @FierceBiotech @endpts @statnews @PharmaScrip @FSSCR_officiel @ISSCR @JSRM_Official @CIRMnews @iPSCellNews @IPSCtherapies @Labiotech_eu @BioPharmaDive @RegMedNet @LabCentral @MassBio @JSRM_Official @LINKJ20160324
143
@treefrogtx team will start 2023 in #SanFrancisco ! Frédéric Desdouits and Kévin Alessandri will attend the J.P. Morgan 41st annual Healthcare Meeting from January 9th to 12th 2023. Feel free to reach out to schedule a meeting. #JPMorgan #celltherapyforall
1
279
Meet us next week at iPSC-Derived Cell Therapies Summit, from December 6th to 7th in Boston ! Feel free to connect with our Boston team, CTO Kévin Alessandri and BD Officer Anthony Renodon, based in @LabCentral (@MassBio). #Boston #celltherapyforall
Load more